HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samuel S W Szeto Selected Research

tetramethylpyrazine nitrone

11/2016Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Samuel S W Szeto Research Topics

Disease

2Infarction (Infarctions)
01/2017 - 11/2016
2Inflammation (Inflammations)
01/2017 - 07/2015
2Cerebral Infarction
11/2016 - 10/2015
2Ischemic Stroke
11/2016 - 10/2015
2Parkinson Disease (Parkinson's Disease)
01/2016 - 07/2015
1Wounds and Injuries (Trauma)
01/2017
1Stroke (Strokes)
11/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2015
1Pheochromocytoma
02/2015
1Hypoxia (Hypoxemia)
09/2007
1Neoplasms (Cancer)
09/2007
1Hyperoxia
09/2007

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2015
3Neuroprotective AgentsIBA
11/2016 - 07/2015
2Peptides (Polypeptides)IBA
10/2015 - 02/2015
1Free RadicalsIBA
11/2016
1tetramethylpyrazine nitroneIBA
11/2016
1Therapeutic UsesIBA
11/2016
1tetramethylpyrazineIBA
11/2016
1VimentinIBA
11/2016
1oxyphylla AIBA
01/2016
1Biological ProductsIBA
01/2016
1AcidsIBA
01/2016
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2015
1AnionsIBA
10/2015
1Tyrosine (L-Tyrosine)FDA Link
10/2015
1CationsIBA
10/2015
1Drug CombinationsIBA
07/2015
1chrysinIBA
07/2015
1AntioxidantsIBA
07/2015
1protocatechuic acidIBA
07/2015
1ProteomeIBA
02/2015
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
09/2007
1EnzymesIBA
09/2007
1ParaquatIBA
09/2007
1Superoxides (Superoxide)IBA
09/2007
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2007
1Succinic Acid (Succinate)IBA
09/2007

Therapy/Procedure

3Therapeutics
01/2017 - 07/2015